PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26639427-6	2016	Notably, melatonin/memantine combination decreased brain injury and DNA fragmentation significantly, which was associated with reduced p38 and ERK-1/2 phosphorylation.	Memantine	19-28	mitogen-activated protein kinase 3	Homo sapiens	143-150	
30651113-0	2019	Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of Kv1.3 potassium channels, AKT and ERK1/2 signaling.	Memantine	0-9	mitogen-activated protein kinase 3	Homo sapiens	135-141	
30651113-9	2019	Molecular effects of memantine co-treatment on activation of Caspases, AKT, ERK1/2, and JNK signaling were analysed by Western blot.	Memantine	21-30	mitogen-activated protein kinase 3	Homo sapiens	76-82	
30651113-12	2019	At molecular level, memantine co-application fosters concurrent inhibition of AKT, S6 and ERK1/2 and reinforces nuclear down-regulation of MYC, a common target of AKT and ERK1/2 signaling.	Memantine	20-29	mitogen-activated protein kinase 3	Homo sapiens	90-96	
30651113-12	2019	At molecular level, memantine co-application fosters concurrent inhibition of AKT, S6 and ERK1/2 and reinforces nuclear down-regulation of MYC, a common target of AKT and ERK1/2 signaling.	Memantine	20-29	mitogen-activated protein kinase 3	Homo sapiens	171-177	
25421211-10	2016	Furthermore, we found that developmental sevoflurane-induced phospho-ERK1/2 inhibition was restored by synaptic NMDA receptor activation (in vitro), low dose of NMDA (in vitro) or memantine (in vivo).	Memantine	180-189	mitogen-activated protein kinase 3	Homo sapiens	69-75